CF
GLSI icon

Corebridge Financial’s Greenwich LifeSciences GLSI Stock Holding History

Corebridge Financial’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,985
Closed -$28.5K – 1114
2025
Q1 		$28.5K Sell
2,985
-44
-1% -$534 ﹤0.01% 2852
2024
Q4 		$34K Sell
3,029
-162
-5% -$2.17K ﹤0.01% 2905
2024
Q3 		$45.9K Sell
3,191
-21
-0.7% -$311 ﹤0.01% 2885
2024
Q2 		$55.5K Buy
+3,212
New +$46.9K ﹤0.01% 2874

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Corebridge Financial's GLSI Position: Q2 2025 in Review

Corebridge Financial sold out of Greenwich LifeSciences (GLSI) in Q2 2025, closing a stake of 2,985 shares — an estimated $28.5K sold.

Corebridge Financial first reported a position in GLSI in Q2 2024 and held it in 4 quarters. The position peaked at $55.5K in Q2 2024. 51 funds tracked by Wall St. Rank hold GLSI as of Q2 2025.

  • Corebridge Financial reported no remaining Greenwich LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 2,985 Greenwich LifeSciences shares in Q2 2025, an estimated $28.5K.
  • Corebridge Financial first reported a position in Greenwich LifeSciences in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Greenwich LifeSciences position peaked at $55.5K in Q2 2024.
  • 51 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.